Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 27, 886–888 (1 October 2009) | doi:10.1038/nbt1009-886
Is it virtuous to be virtual? The VC viewpoint
&
Abstract
To the Editor: A Commentary in the August issue by Bruce Booth highlights the importance of the virtual business model as an increasingly important facet of strategies for making biotech companies more capital efficient. In a previous study examining the portfolio companies of his venture capital (VC) firm, Booth also provided evidence that companies with fewer full-time employees are markedly more productive than peer companies with more employees.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
